Dynamic Changes in Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis with Respect to Antibiotic Susceptibility
Young Woo Um,Inwon Park,Jae Hyuk Lee,Hee Eun Kim,Dongkwan Han,Seung Hyun Kang,Seonghye Kim,You Hwan Jo
DOI: https://doi.org/10.2147/idr.s464286
2024-05-29
Infection and Drug Resistance
Abstract:Young Woo Um, 1 Inwon Park, 1 Jae Hyuk Lee, 1 Hee Eun Kim, 1 Dongkwan Han, 1 Seung Hyun Kang, 1 Seonghye Kim, 1 You Hwan Jo 1– 3 1 Department of Emergency Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea; 2 Department of Emergency Medicine, Seoul National University College of Medicine, Seoul, Korea; 3 Disaster Medicine Research Center, Seoul National University Medical Research Center, Seoul, Korea Correspondence: Jae Hyuk Lee, Department of Emergency Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Korea, Tel +82-31-787-7579, Fax +82-31-787-4055, Email Purpose: Proper antibiotic administration is crucial for sepsis management. Given the escalating incidence of antimicrobial resistance, there is a pressing need for indicators of antimicrobial susceptibility with short turnaround times. This study aimed to investigate the potential of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as an early biomarker for in vivo antibiotic susceptibility in patients with sepsis. Patients and Methods: We conducted a retrospective analysis of plasma samples from patients enrolled in a pre-established study designed to investigate prognostic biomarkers in patients with sepsis or septic shock. Baseline and 6 h sTREM-1 levels were examined using enzyme-linked immunosorbent assays. The primary outcome of the study was the comparison of percentage changes in sTREM-1 levels at the 6 h relative to baseline with respect to antibiotic susceptibility. Results: Of the 596 patients enrolled in the pre-established study, 29 with a median age of 75.8 and a 28-day mortality rate of 17.2% were included in the present analysis. Among these patients, 24 were classified into the susceptible group, whereas the remaining five were classified into the resistant group. The trend in plasma sTREM-1 levels differed with respect to antibiotic susceptibility. Moreover, percentage change in sTREM-1 levels at the 6 h relative to baseline was significantly higher in the resistant group ( P = 0.028). Conclusion: The trend in plasma sTREM-1 levels in patients with sepsis differed with respect to antibiotic susceptibility, with a higher percentage change in patients treated with inappropriate antibiotics. These findings indicate the potential utility of sTREM-1 as an early biomarker of antibiotic susceptibility. Keywords: anti-bacterial agents, biomarkers, drug resistance, sepsis, triggering receptor expressed on myeloid cells-1 Timely and appropriate administration of antibiotics is crucial in sepsis management to improve patient survival. 1–3 Confirming the pathogen and its antimicrobial susceptibility is essential for achieving this objective. While blood culture is the gold standard for pathogen identification, 4,5 its extended turnaround times and potential failure to detect slow-growing pathogens pose significant limitations. 6,7 Furthermore, a significant proportion of sepsis cases yields negative blood culture results, 8,9 further restricting its clinical utility in guiding antibiotic selection. 8 Moreover, global rise in antimicrobial resistance adds complexity to antibiotic selection. 10 Therefore, development of rapid and accurate techniques for pathogen identification and susceptibility testing are imperative. 6,11 Additionally, there is a need for biomarkers that reflect the patient's response to antibiotics, aiding clinical decision-making alongside microbiological tests. 12,13 Although, several biomarkers have been explored for assessing treatment response in sepsis, 14–16 most rely on daily measurements, lacking time-related advantages compared to blood culture tests. Furthermore, our understanding of host biomarkers for treatment response, particularly concerning in vivo antibiotic susceptibility, remains limited. A previous study investigated dynamic alterations in hemodynamics and plasma biomarkers with respect to antibiotic susceptibility in a porcine model of bacteremia. 17 While there were no significant differences in hemodynamics and other biomarkers, the plasma level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) exhibited significant differences in relation to antibiotic susceptibility over time. TREM-1 is a transmembrane receptor of the immunoglobulin superfamily that is mainly expressed on myeloid cells and is upregulated during infections. 18,19 Based on these findings, the authors proposed that sTREM-1 could potentially serve as a biomarker for in vivo antibiotic s -Abstract Truncated-
pharmacology & pharmacy,infectious diseases